TNXP Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.

$1.62  +0.04 (2.22%)
As of 07/01/2022 15:58:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/03/2012
Outstanding shares:  533,928,624
Average volume:  5,771,703
Market cap:   $886,321,516
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BK26FH7
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.13
PS ratio:   0.00
Return on equity:   -47.15%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy